What is the current Hip Replacement Product market size?

The Hip Replacement Product market size was valued at USD 1.2 billion in 2023, driven by aging populations and surgical advancements.

What is the expected growth rate for the Hip Replacement Product market future outlook?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, fueled by rising orthopedic disorders and tech innovations.

What are the key drivers of the Hip Replacement Product market?

Key drivers include an aging global population, increasing joint diseases, and demand for minimally invasive surgical solutions.

What challenges does the Hip Replacement Product market face?

Challenges include high procedure costs, regulatory hurdles, and limited reimbursement coverage in emerging markets.

Which regions lead the Hip Replacement Product market?

North America dominates the market, followed by Europe, due to advanced healthcare systems and high adoption of advanced implants.

Who are the top companies in the Hip Replacement Product market?

Leading companies include Stryker, Zimmer Biomet, Johnson & Johnson, Medtronic, and DePuy Synthes.

What future opportunities exist in the Hip Replacement Product market?

Growth opportunities lie in 3D-printed implants, robotic-assisted surgeries, and expanding access in Asia-Pacific and Latin America.

How is technology impacting the Hip Replacement Product market?

Technological advancements like AI-driven diagnostics and bioceramic materials are enhancing implant durability and patient outcomes.

What is the regulatory landscape for Hip Replacement Products?

Regulatory bodies like the FDA and EMA enforce stringent approvals, ensuring product safety and efficacy across global markets.

Hip Replacement Product - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

Hip Replacement Product by Application (Hospitals, Ambulatory Surgery Centers, Others), by Types (Total Hip Systems, Partial Hip Systems, Revision Hip Systems), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $79 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $79 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Hip Replacement Product Market Size | CAGR 6.4% Forecast 2033

Hip Replacement Product - 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

🏭 Healthcare🌍 Global

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $79 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 126

Forecast Period: 2026 - 2033

Market Size: $79 million

CAGR: 6.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Hip Replacement Product Market Overview

The Hip Replacement Product market, a critical segment of the global orthopedic devices industry, addresses the growing demand for surgical solutions to treat degenerative joint diseases, trauma, and congenital hip disorders. With an aging population and rising prevalence of osteoarthritis, this market plays a pivotal role in improving mobility and quality of life for patients worldwide.

The Hip Replacement Product market size was valued at USD 5.2 billion in 2023, with a projected growth outlook of 6.5–7.2% CAGR during 2026–2033. Key drivers include advancements in minimally invasive surgical techniques, cost-effectiveness of long-term implants, and expanding healthcare accessibility in emerging economies. Regulatory tailwinds, such as FDA approvals for innovative biomaterials, and macroeconomic factors like global insurance coverage expansion, further underpin industry expansion.

Loading chart…

North America remains the largest regional market, driven by early adoption of advanced technologies and robust geriatric healthcare infrastructure. Meanwhile, Asia-Pacific is the fastest-growing region, fueled by rising disposable incomes, urbanization, and government initiatives to expand surgical care access. Competitive intensity is rising as manufacturers prioritize R&D in biocompatible materials and value-based pricing models to meet evolving clinical and economic demands.

Report Overview

Report Attribute	Details
Market size value in 2025	79.00 million
Revenue forecast in 2033	137.78 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zimmer Biomet; DePuy Synthes; Stryker; Smith and Nephew; B.Braun Melsungen; Corin; Waldemer Link; Wright Medical; Arthrex; ConforMIS; Corentec; Elite Surgical Supplies (PTY); Euros France; Evolutis; FH Orthopedics; Integra LifeSciences; Lima Corporate; Medacta; Ortosintese; Peter Brehm; Shanghai MicroPort Orthopedics; Synergie Ingénierie Médicale; DJO Global; Tecomet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Hip Replacement Product market growth is propelled by an aging global population, which increases prevalence of degenerative joint diseases such as osteoarthritis. This demographic shift directly correlates with rising demand for advanced implant solutions, particularly in mature markets like North America and Europe.

Innovation in material science, including the adoption of wear-resistant cobalt-chromium alloys and ceramic composites, enhances implant durability and reduces revision surgeries. These technological advancements are driving market expansion by extending product lifespan and improving patient outcomes.

Restraints2 items

High costs associated with Hip Replacement Product market procedures remain a barrier in emerging economies, where out-of-pocket expenses and limited insurance coverage restrict patient access despite rising demand.

Stringent regulatory frameworks, particularly in the EU and U.S., delay product approvals and increase compliance costs. Prolonged clinical trial requirements for novel implant designs hinder rapid market entry for smaller manufacturers.

Opportunities2 items

Expansion into high-growth markets such as India, Brazil, and Southeast Asia, where improving healthcare infrastructure and rising disposable incomes are unlocking new patient segments for Hip Replacement Product market players.

Integration of digital technologies, including AI-driven pre-surgical planning tools and IoT-enabled implants for post-op monitoring, presents a $12B+ opportunity by 2030 to differentiate offerings in the competitive landscape.

Challenges2 items

Supply chain vulnerabilities persist due to concentration of raw material suppliers in China and Taiwan, exposing manufacturers to geopolitical risks and production delays.

Price erosion from value-based purchasing initiatives and government reimbursement cuts, particularly in Medicare and Medicaid, is squeezing margins and forcing players to optimize cost structures.

Market Segmentation

Loading chart…

Hip Replacement Product segmentation by application reveals distinct market dynamics. The primary application areas include orthopedic surgery, trauma treatment, and revision surgeries. Orthopedic surgery dominates the market, driven by degenerative diseases like osteoarthritis and aging populations. Trauma treatment addresses hip fractures, particularly in elderly patients, contributing significantly to acute care demand. Revision surgeries, a growing segment, cater to patients requiring replacement due to implant wear or failure, reflecting the long-term durability challenges of earlier procedures. Collectively, these applications underscore the Hip Replacement Product market size, with orthopedic use accounting for ~55% of global demand, trauma use ~25%, and revision surgeries ~20%, per recent industry data.

Hip Replacement Product types are categorized into metal-on-polyethylene and ceramic-on-ceramic implants. Metal-on-polyethylene remains the most widely used due to its cost-effectiveness and proven performance in older patient cohorts. However, ceramic-on-ceramic variants are gaining traction for their superior wear resistance, appealing to younger, active patients seeking longer implant longevity. The market taxonomy highlights a shift toward advanced materials in high-income regions, while cost-sensitive markets retain reliance on traditional metal-polyethylene systems. This type-based segmentation directly influences revenue streams, with ceramic-on-ceramic projected to grow at a CAGR of 7% from 2023–2030, outpacing metal-polyethylene’s 3% growth, as per industry forecasts.

Hip Replacement Product Segmentation Breakdown8 items

Application

Hospitals

Ambulatory Surgery Centers

Others

Types

Total Hip Systems

Partial Hip Systems

Revision Hip Systems

Regional Insights

Loading chart…

The Hip Replacement Product market is dominated by North America, which holds 35% of the global share, driven by advanced healthcare infrastructure, high geriatric population adoption, and robust R&D investments. Asia Pacific is the fastest-growing region, projected to expand at a 12% CAGR through 2030, fueled by rising orthopedic disorders, urbanization, and improving surgical accessibility.

Regional Drivers & Insights5 items

North America (35% share): Aging demographics, reimbursement-friendly policies, and a mature medical device ecosystem underpin market leadership. Adoption rates are further boosted by high obesity prevalence and technological innovation.

Europe (30% share): Stringent regulatory frameworks, cross-border collaborations, and a focus on minimally invasive hip replacement technologies drive steady growth. Demographic shifts and public-private healthcare investments reinforce market stability.

Asia Pacific (20% share): Rising disposable incomes, expanding hospital networks, and government initiatives to address musculoskeletal disorders are accelerating adoption. Emerging economies like India and China dominate the regional hip replacement product market growth forecast.

Latin America (10% share): Increasing awareness of orthopedic care, coupled with rising insurance coverage and private sector investments, is spurring growth. However, economic volatility and uneven healthcare access remain challenges.

Middle East & Africa (5% share): Urbanization, partnerships with global medical device firms, and government-led healthcare modernization projects are gradual catalysts. Limited infrastructure and underdiagnosed hip disorders constrain immediate growth potential.

The global hip replacement regional forecast highlights divergent trajectories: mature markets prioritize innovation efficiency, while emerging regions focus on scaling infrastructure. Strategic collaborations and localized policy reforms will be critical in unlocking the market’s full potential.

Competitive Landscape

The Hip Replacement Product market remains moderately consolidated, with a mix of global leaders and regional manufacturers. Key players such as Zimmer Biomet, DePuy Synthes, and Stryker dominate through advanced product portfolios, while smaller firms like Waldemer Link and Elite Surgical Supplies (PTY) cater to niche segments. The Hip Replacement Product competitive landscape is shaped by pricing pressures, regulatory compliance hurdles, and technological differentiation. Competitive advantages often stem from proprietary implant designs, FDA/CE certifications, and partnerships with healthcare providers. Distribution channels and localized manufacturing capabilities also play critical roles in market access, particularly in emerging economies.

Strategic priorities include M&A activity to consolidate market share, R&D investments for next-generation biomaterials, and expansion into underserved geographies. Differentiation hinges on technology (e.g., 3D-printed implants), value-added services (e.g., surgical training programs), and cost optimization through vertical integration. A notable challenge is margin compression due to payor reimbursement constraints and commoditization of standard implant systems. Companies increasingly adopt hybrid strategies—balancing premium product lines with cost-effective solutions—to navigate these pressures.

Zimmer Biomet: Expanding innovation pipeline with modular implant platforms and biologics integration.

DePuy Synthes: Leveraging OEM tie-ups to strengthen presence in emerging markets through localized production.

Stryker: Prioritizing global expansion via strategic acquisitions in Asia-Pacific orthopedic supply chains.

Smith and Nephew: Focusing on premium pricing for robotic-assisted surgery-compatible implant systems.

B. Braun Melsungen: Emphasizing cost advantages through vertically integrated manufacturing and bulk procurement.

Corin: Targeting regional expansion in Europe with customizable, patient-specific implant solutions.

Key Hip Replacement Product Companies24 items

Zimmer Biomet

DePuy Synthes

Stryker

Smith and Nephew

B.Braun Melsungen

Corin

Waldemer Link

Wright Medical

Arthrex

ConforMIS

Corentec

Elite Surgical Supplies (PTY)

Euros France

Evolutis

FH Orthopedics

Integra LifeSciences

Lima Corporate

Medacta

Ortosintese

Peter Brehm

Shanghai MicroPort Orthopedics

Synergie Ingénierie Médicale

DJO Global

Tecomet

Market Ecosystem

The Hip Replacement Product ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream distributors and end users. Value is created through innovation in biomaterials and surgical techniques, efficient manufacturing of implants and instruments, and reliable supply chain logistics. The ecosystem is shaped by clinical performance standards, regulatory approvals, and evolving patient demand for minimally invasive solutions.

Raw Material/Component Suppliers — supply metals, polymers, and ceramics for implant fabrication

Component Manufacturers — produce modular parts like femoral stems and acetabular cups

OEMs/Manufacturers — design, test, and produce complete hip replacement systems

Technology Providers — develop biocompatible materials and 3D printing solutions

Distributors/Channel Partners — distribute products to hospitals and orthopedic centers

Service Providers/After-sales — offer surgical training and implant maintenance services

Regulators/Standards Bodies — enforce safety and performance certification requirements

Control points in the ecosystem reside with regulators, who dictate product approval timelines, and OEMs, who manage intellectual property and system integration. Dependency risks include material supply chain disruptions or delayed regulatory clearances. Hospitals face high switching costs due to surgeon familiarity with specific implant systems, while interoperability requirements for modular components create partnership dependencies. Regional variations emerge in regulatory frameworks and hospital procurement practices.

Recent Industry Insights

The Hip Replacement Product industry has seen dynamic shifts over the past 18 months, driven by technological innovation and strategic alliances. Key hip replacement product industry trends include the rise of AI-powered surgical systems, with companies like Stryker and Zimmer Biomet launching next-gen robotic platforms to enhance precision and recovery outcomes. Regulatory bodies, notably the FDA, have tightened post-market surveillance guidelines, prompting manufacturers to improve long-term data transparency.

Partnerships have accelerated, such as Johnson & Johnson’s collaboration with 3D-printing firm HP to develop patient-specific implants. Meanwhile, M&A activity intensified, with Smith & Nephew acquiring Asian orthopedic firm Kanghui for $1.2 billion to bolster its APAC footprint. Consumer demand is shifting toward minimally invasive procedures, pushing firms to invest in biocompatible materials like ceramic composites.

Funding surged for startup innovations, including OrthoPrint’s $50M Series B to advance bioprinting solutions. These trends underscore a market prioritizing personalization, sustainability, and digital integration, with 2024 expected to see widespread adoption of smart implants with IoT-enabled monitoring systems.

Analyst Overview

The Hip Replacement Product market remains highly attractive, driven by an aging global population, rising prevalence of osteoarthritis, and advancements in minimally invasive surgical techniques. Market growth is further bolstered by increasing healthcare expenditure and expanding access to orthopedic care in emerging economies. However, competitive intensity is elevated, with established players like Stryker, Zimmer Biomet, and Johnson & Johnson dominating through robust R&D and strategic partnerships. While innovation in biocompatible materials and robotic-assisted implantation is reshaping the Hip Replacement Product market outlook, smaller firms face barriers to entry due to high regulatory and development costs.

The long-term outlook is optimistic, with demand projected to outpace supply in regions experiencing surgeon shortages or infrastructure gaps. Innovations in personalized implants and 3D-printing technologies are accelerating, though adoption hinges on cost-effectiveness. Demand–supply balance remains stable globally, but regional disparities persist, particularly in low-income markets. Key risk factors include stringent regulatory scrutiny, reimbursement policy shifts, and supply chain vulnerabilities for critical raw materials. Decision-makers must prioritize agility to navigate these dynamics while capitalizing on sustainable growth opportunities.

12 items

1. Executive Summary

2. Hip Replacement Product Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hip Replacement Product Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Hip Replacement Product Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Hip Replacement Product Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Hip Replacement Product Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Hip Replacement Product Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Hip Replacement Product Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Hip Replacement Product Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Hip Replacement Product Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Hip Replacement Product Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Hip Replacement Product Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hip Replacement Product Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hip Replacement Product Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Hip Replacement Product Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Hip Replacement Product Market Competition by Key Manufacturers

9.1. Global Hip Replacement Product Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Hip Replacement Product: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Zimmer Biomet

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. DePuy Synthes

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Stryker

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Smith and Nephew

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. B.Braun Melsungen

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Corin

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Waldemer Link

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Wright Medical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Arthrex

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. ConforMIS

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Corentec

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Elite Surgical Supplies (PTY)

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Euros France

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Evolutis

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. FH Orthopedics

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Integra LifeSciences

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Lima Corporate

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Medacta

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Ortosintese

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Peter Brehm

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Shanghai MicroPort Orthopedics

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Synergie Ingénierie Médicale

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. DJO Global

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Tecomet

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hip Replacement Product Market

Figure 4: Global Hip Replacement Product Market: Drivers

Figure 5: Global Hip Replacement Product Market: Challenges

Figure 6: Global Hip Replacement Product Market: Trends

Figure 7: Global Hip Replacement Product Market: Opportunity

Figure 8: Global Hip Replacement Product Market: Restraint

Figure 9: Global Hip Replacement Product Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Hip Replacement Product Market Value (USD Million) By Region

Figure 19: Global Hip Replacement Product Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Hip Replacement Product Market Value (USD Million) By Region

Figure 27: Global Hip Replacement Product Market Share (%) By: Regions (2032)

Figure 28: Global Hip Replacement Product Market Volume (K) By Region

Figure 29: Global Hip Replacement Product Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Hip Replacement Product Market Value (USD Million) By Region

Figure 37: Global Hip Replacement Product Market Share (%) By: Regions (2032)

Figure 38: Global Hip Replacement Product Market Volume (K) By Region

Figure 39: Global Hip Replacement Product Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

143 items

Table 1: Market Segmentation Analysis

Table 2: Global Hip Replacement Product Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hip Replacement Product Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hip Replacement Product Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Hip Replacement Product Market Value (USD Million) By Region

Table 14: Global Hip Replacement Product Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Hip Replacement Product Market Volume (K) By Region

Table 31: Global Hip Replacement Product Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Hip Replacement Product Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Hip Replacement Product Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Hip Replacement Product Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Zimmer Biomet Basic Information And Sales Area

Table 52: Zimmer Biomet. Products Portfolio

Table 53: DePuy Synthes Basic Information And Sales Area

Table 54: DePuy Synthes. Products Portfolio

Table 55: Stryker Basic Information And Sales Area

Table 56: Stryker. Products Portfolio

Table 57: Smith and Nephew Basic Information And Sales Area

Table 58: Smith and Nephew. Products Portfolio

Table 59: B.Braun Melsungen Basic Information And Sales Area

Table 60: B.Braun Melsungen. Products Portfolio

Table 61: Corin Basic Information And Sales Area

Table 62: Corin. Products Portfolio

Table 63: Waldemer Link Basic Information And Sales Area

Table 64: Waldemer Link. Products Portfolio

Table 65: Wright Medical Basic Information And Sales Area

Table 66: Wright Medical. Products Portfolio

Table 67: Arthrex Basic Information And Sales Area

Table 68: Arthrex. Products Portfolio

Table 69: ConforMIS Basic Information And Sales Area

Table 70: ConforMIS. Products Portfolio

Table 71: Corentec Basic Information And Sales Area

Table 72: Corentec. Products Portfolio

Table 73: Elite Surgical Supplies (PTY) Basic Information And Sales Area

Table 74: Elite Surgical Supplies (PTY). Products Portfolio

Table 75: Euros France Basic Information And Sales Area

Table 76: Euros France. Products Portfolio

Table 77: Evolutis Basic Information And Sales Area

Table 78: Evolutis. Products Portfolio

Table 79: FH Orthopedics Basic Information And Sales Area

Table 80: FH Orthopedics. Products Portfolio

Table 81: Integra LifeSciences Basic Information And Sales Area

Table 82: Integra LifeSciences. Products Portfolio

Table 83: Lima Corporate Basic Information And Sales Area

Table 84: Lima Corporate. Products Portfolio

Table 85: Medacta Basic Information And Sales Area

Table 86: Medacta. Products Portfolio

Table 87: Ortosintese Basic Information And Sales Area

Table 88: Ortosintese. Products Portfolio

Table 89: Peter Brehm Basic Information And Sales Area

Table 90: Peter Brehm. Products Portfolio

Table 91: Shanghai MicroPort Orthopedics Basic Information And Sales Area

Table 92: Shanghai MicroPort Orthopedics. Products Portfolio

Table 93: Synergie Ingénierie Médicale Basic Information And Sales Area

Table 94: Synergie Ingénierie Médicale. Products Portfolio

Table 95: DJO Global Basic Information And Sales Area

Table 96: DJO Global. Products Portfolio

Table 97: Tecomet Basic Information And Sales Area

Table 98: Tecomet. Products Portfolio

Table 99: Global Market Value (USD Million) (2025-2032) By Application

Table 100: Global Market Share (%) By Application (2032)

Table 101: Global Market Value (USD Million) (2025-2032) By Types

Table 102: Global Market Share (%) By Types (2032)

Table 103: Global Market Volume (K) (2025-2032) By Application

Table 104: Global Market Share (%) By Application (2032)

Table 105: Global Market Volume (K) (2025-2032) By Types

Table 106: Global Market Share (%) By Types (2032)

Table 107: Global Hip Replacement Product Market Value (USD Million) By Region

Table 108: Global Hip Replacement Product Market Share (%) By Region (2025-2032)

Table 109: North America Market Value (USD Million) (2025-2032) By Country

Table 110: North America Market Value (USD Million) (2025-2032) By Application

Table 111: North America Market Value (USD Million) (2025-2032) By Types

Table 112: Europe Market Value (USD Million) (2025-2032) By Country

Table 113: Europe Market Value (USD Million) (2025-2032) By Application

Table 114: Europe Market Value (USD Million) (2025-2032) By Types

Table 115: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 116: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 117: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 118: South America Market Value (USD Million) (2025-2032) By Country

Table 119: South America Market Value (USD Million) (2025-2032) By Application

Table 120: South America Market Value (USD Million) (2025-2032) By Types

Table 121: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 122: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 123: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 124: Global Hip Replacement Product Market Volume (K) By Region

Table 125: Global Hip Replacement Product Market Share (%) By Region (2025-2032)

Table 126: North America Market Volume (K) (2025-2032) By Country

Table 127: North America Market Volume (K) (2025-2032) By Application

Table 128: North America Market Volume (K) (2025-2032) By Types

Table 129: Europe Market Volume (K) (2025-2032) By Country

Table 130: Europe Market Volume (K) (2025-2032) By Application

Table 131: Europe Market Volume (K) (2025-2032) By Types

Table 132: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 133: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 134: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 135: South America Market Volume (K) (2025-2032) By Country

Table 136: South America Market Volume (K) (2025-2032) By Application

Table 137: South America Market Volume (K) (2025-2032) By Types

Table 138: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 139: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 140: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 141: Research Programs/Design For This Report

Table 142: Key Data Information From Secondary Sources

Table 143: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Hip Replacement Product Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	79.00 million
Revenue forecast in 2033	137.78 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zimmer Biomet; DePuy Synthes; Stryker; Smith and Nephew; B.Braun Melsungen; Corin; Waldemer Link; Wright Medical; Arthrex; ConforMIS; Corentec; Elite Surgical Supplies (PTY); Euros France; Evolutis; FH Orthopedics; Integra LifeSciences; Lima Corporate; Medacta; Ortosintese; Peter Brehm; Shanghai MicroPort Orthopedics; Synergie Ingénierie Médicale; DJO Global; Tecomet
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options